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Background: In patients with STEMI and multivessel disease (MVD), ACC/AHA guidelines classify PCI of a noninfarct vessel as Class III unless there 
is hemodynamic instability. We hypothesized that, with rapid door-to-balloon time and favorable anatomy, outcomes for multivessel PCI during STEMI 
would be comparable to infarct-vessel-only PCI with staging of the second artery.
Methods: We reviewed 2,132 consecutive STEMI patients presenting to a single hospital with an interventionalist in-house 24/7/365 from Jan. 
2002 to Oct. 2010. Of those, 724 (34%) had MVD, defined as >1 vessel with ≥70% stenosis. Patients with shock (n=155), prior CABG (n=122) or 
thrombolytics (n=23) were excluded, leaving 424. Multivessel PCI was performed in 111; in 313, infarct-vessel-only PCI was performed followed by 
staged PCI at mean 19.5 days.
Results: There were no differences in clinical characteristics between the two groups. Combining total hospital days for staged PCI, length of stay 
was 3.9 days for multivessel PCI vs. 6.5 days for staged PCI (p<0.0001), with 30% less hospital charges ($30,228 difference; p<0.0001).
Conclusions: For STEMI patients with multivessel disease, a subgroup with rapid reperfusion and no hemodynamic compromise can have 
noninfarct-artery PCI at presentation with excellent outcomes, significantly shorter total length of stay, and substantial cost savings compared to 
staged PCI. These data warrant a prospective trial for confirmation and/or modification of the current ACC/AHA guidelines.
